Nicole Schmitz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nicole Schmitz has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
Lieuwe de Haan
11 shared publications- Eileen Daly
Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
10 shared publications - Declan Gm Murphy
Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia
9 shared publications Therese van Amelsvoort
9 shared publicationsDon Linszen
7 shared publications- Kieran C. Murphy
Department of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland
6 shared publications
Latest Publications
- 1 November 2013
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 23 (11) , 1577-1586
Dopaminergic modulation of the reward system in schizophrenia: A placebo-controlled dopamine depletion fMRI study
- 1 November 2013
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 23 (11) , 1577-1586
Dopaminergic modulation of the reward system in schizophrenia: A placebo-controlled dopamine depletion fMRI study
- 25 March 2013
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 12 (4) , 1847-1855
Imaging Mass Spectrometry-based Molecular Histology Differentiates Microscopically Identical and Heterogeneous Tumors
Many tumors display significant cellular heterogeneity as well as molecular heterogeneity. Sensitive biomarkers that differentiate between diagnostically challenging tumors must contend with this heterogeneity. Mass spectrometry-based molecular histology of a patient series of heterogeneous, microscopically identical bone tumors highlighted the tumor cell types that could be characterized by a single profile and led to the identification of specific peptides that differentiate between the tumors.
- 25 March 2013
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 12 (4) , 1847-1855
Imaging Mass Spectrometry-based Molecular Histology Differentiates Microscopically Identical and Heterogeneous Tumors
Many tumors display significant cellular heterogeneity as well as molecular heterogeneity. Sensitive biomarkers that differentiate between diagnostically challenging tumors must contend with this heterogeneity. Mass spectrometry-based molecular histology of a patient series of heterogeneous, microscopically identical bone tumors highlighted the tumor cell types that could be characterized by a single profile and led to the identification of specific peptides that differentiate between the tumors.
- 1 April 2012
- Published by Elsevier in Schizophrenia Research
- Vol. 136, S98-S99
Poster #20 DOPAMINERGIC MODULATION OF THE REWARD SYSTEM IN SCHIZOPHRENIA: A PLACEBO-CONTROLLED DOPAMINE DEPLETION FMRI STUDY
- 1 April 2012
- Published by Elsevier in Schizophrenia Research
- Vol. 136, S98-S99
Poster #20 DOPAMINERGIC MODULATION OF THE REWARD SYSTEM IN SCHIZOPHRENIA: A PLACEBO-CONTROLLED DOPAMINE DEPLETION FMRI STUDY
- 30 January 2012
- Published by SAGE Publications in Cephalalgia
- Vol. 32 (4) , 279-288
Cerebral perfusion changes in migraineurs: a voxelwise comparison of interictal dynamic susceptibility contrast MRI measurements
Introduction: The increased risk of cerebro- and cardiovascular disease in migraineurs may be the consequence of a systemic condition affecting whole body vasculature. At cerebrovascular level, this may be reflected by interictal global or regional cerebral perfusion abnormalities. Whether focal perfusion changes occur during interictal migraine has not been convincingly demonstrated.
- 30 January 2012
- Published by SAGE Publications in Cephalalgia
- Vol. 32 (4) , 279-288
Cerebral perfusion changes in migraineurs: a voxelwise comparison of interictal dynamic susceptibility contrast MRI measurements
Introduction: The increased risk of cerebro- and cardiovascular disease in migraineurs may be the consequence of a systemic condition affecting whole body vasculature. At cerebrovascular level, this may be reflected by interictal global or regional cerebral perfusion abnormalities. Whether focal perfusion changes occur during interictal migraine has not been convincingly demonstrated.
- 1 October 2011
- Published by Elsevier in Schizophrenia Research
- Vol. 132 (1) , 75-83
White matter abnormalities in adults with 22q11 deletion syndrome with and without schizophrenia
- 1 October 2011
- Published by Elsevier in Schizophrenia Research
- Vol. 132 (1) , 75-83
White matter abnormalities in adults with 22q11 deletion syndrome with and without schizophrenia
- 1 October 2011
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 194 (1) , 1-6
Semantic fluency deficits and reduced grey matter before transition to psychosis: A voxelwise correlational analysis
- 1 October 2011
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 194 (1) , 1-6
Semantic fluency deficits and reduced grey matter before transition to psychosis: A voxelwise correlational analysis
- Open Access
- 30 June 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (6) , e21685
Proton Magnetic Resonance Spectroscopy in 22q11 Deletion Syndrome
People with velo-cardio-facial syndrome or 22q11 deletion syndrome (22q11DS) have behavioral, cognitive and psychiatric problems. Approximately 30% of affected individuals develop schizophrenia-like psychosis. Glutamate dysfunction is thought to play a crucial role in schizophrenia. However, it is unknown if and how the glutamate system is altered in 22q11DS. People with 22q11DS are vulnerable for haploinsufficiency of PRODH, a gene that codes for an enzyme converting proline into glutamate. Therefore, it can be hypothesized that glutamatergic abnormalities may be present in 22q11DS. We employed proton magnetic resonance spectroscopy (1H-MRS) to quantify glutamate and other neurometabolites in the dorsolateral prefrontal cortex (DLPFC) and hippocampus of 22 adults with 22q11DS (22q11DS SCZ+) and without (22q11DS SCZ−) schizophrenia and 23 age-matched healthy controls. Also, plasma proline levels were determined in the 22q11DS group. We found significantly increased concentrations of glutamate and myo-inositol in the hippocampal region of 22q11DS SCZ+ compared to 22q11DS SCZ−. There were no significant differences in levels of plasma proline between 22q11DS SCZ+ and 22q11DS SCZ−. There was no relationship between plasma proline and cerebral glutamate in 22q11DS. This is the first in vivo 1H-MRS study in 22q11DS. Our results suggest vulnerability of the hippocampus in the psychopathology of 22q11DS SCZ+. Altered hippocampal glutamate and myo-inositol metabolism may partially explain the psychotic symptoms and cognitive impairments seen in this group of patients.
- 30 June 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (6) , e21685
Open AccessProton Magnetic Resonance Spectroscopy in 22q11 Deletion Syndrome
People with velo-cardio-facial syndrome or 22q11 deletion syndrome (22q11DS) have behavioral, cognitive and psychiatric problems. Approximately 30% of affected individuals develop schizophrenia-like psychosis. Glutamate dysfunction is thought to play a crucial role in schizophrenia. However, it is unknown if and how the glutamate system is altered in 22q11DS. People with 22q11DS are vulnerable for haploinsufficiency of PRODH, a gene that codes for an enzyme converting proline into glutamate. Therefore, it can be hypothesized that glutamatergic abnormalities may be present in 22q11DS. We employed proton magnetic resonance spectroscopy (1H-MRS) to quantify glutamate and other neurometabolites in the dorsolateral prefrontal cortex (DLPFC) and hippocampus of 22 adults with 22q11DS (22q11DS SCZ+) and without (22q11DS SCZ−) schizophrenia and 23 age-matched healthy controls. Also, plasma proline levels were determined in the 22q11DS group. We found significantly increased concentrations of glutamate and myo-inositol in the hippocampal region of 22q11DS SCZ+ compared to 22q11DS SCZ−. There were no significant differences in levels of plasma proline between 22q11DS SCZ+ and 22q11DS SCZ−. There was no relationship between plasma proline and cerebral glutamate in 22q11DS. This is the first in vivo 1H-MRS study in 22q11DS. Our results suggest vulnerability of the hippocampus in the psychopathology of 22q11DS SCZ+. Altered hippocampal glutamate and myo-inositol metabolism may partially explain the psychotic symptoms and cognitive impairments seen in this group of patients.
- 30 January 2011
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 191 (1) , 85
Reply to Fan and Hart
- 30 January 2011
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 191 (1) , 85
Reply to Fan and Hart
- 12 July 2010
- Published by Wiley in Autism Research
- Vol. 3 (5) , 203-213
White matter integrity in Asperger syndrome: a preliminary diffusion tensor magnetic resonance imaging study in adults
Background: Autistic Spectrum Disorder (ASD), including Asperger syndrome and autism, is a highly genetic neurodevelopmental disorder. There is a consensus that ASD has a biological basis, and it has been proposed that it is a “connectivity” disorder. Diffusion Tensor Magnetic Resonance Imaging (DT‐MRI) allows measurement of the microstructural integrity of white matter (a proxy measure of “connectivity”). However, nobody has investigated the microstructural integrity of whole brain white matter in people with Asperger syndrome. Methods: We measured the fractional anisotropy (FA), mean diffusivity (MD) and radial diffusivity (RD) of white matter, using DT‐MRI, in 13 adults with Asperger syndrome and 13 controls. The groups did not differ significantly in overall intelligence and age. FA, MD and RD were assessed using whole brain voxel‐based techniques. Results: Adults with Asperger syndrome had a significantly lower FA than controls in 13 clusters. These were largely bilateral and included white matter in the internal capsule, frontal, temporal, parietal and occipital lobes, cingulum and corpus callosum. Conclusions: Adults with Asperger syndrome have widespread significant differences from controls in white matter microstructural integrity.
- 12 July 2010
- Published by Wiley in Autism Research
- Vol. 3 (5) , 203-213
White matter integrity in Asperger syndrome: a preliminary diffusion tensor magnetic resonance imaging study in adults
Background: Autistic Spectrum Disorder (ASD), including Asperger syndrome and autism, is a highly genetic neurodevelopmental disorder. There is a consensus that ASD has a biological basis, and it has been proposed that it is a “connectivity” disorder. Diffusion Tensor Magnetic Resonance Imaging (DT‐MRI) allows measurement of the microstructural integrity of white matter (a proxy measure of “connectivity”). However, nobody has investigated the microstructural integrity of whole brain white matter in people with Asperger syndrome. Methods: We measured the fractional anisotropy (FA), mean diffusivity (MD) and radial diffusivity (RD) of white matter, using DT‐MRI, in 13 adults with Asperger syndrome and 13 controls. The groups did not differ significantly in overall intelligence and age. FA, MD and RD were assessed using whole brain voxel‐based techniques. Results: Adults with Asperger syndrome had a significantly lower FA than controls in 13 clusters. These were largely bilateral and included white matter in the internal capsule, frontal, temporal, parietal and occipital lobes, cingulum and corpus callosum. Conclusions: Adults with Asperger syndrome have widespread significant differences from controls in white matter microstructural integrity.
- 8 June 2010
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 25 (4) , 538-549
Dopaminergic modulation of the human reward system: a placebo-controlled dopamine depletion fMRI study
Reward related behaviour is linked to dopaminergic neurotransmission. Our aim was to gain insight into dopaminergic involvement in the human reward system. Combining functional magnetic resonance imaging with dopaminergic depletion by α-methylparatyrosine we measured dopamine-related brain activity in 10 healthy volunteers. In addition to blood-oxygen-level-dependent (BOLD) contrast we assessed the effect of dopaminergic depletion on prolactin response, peripheral markers for dopamine and norepinephrine. In the placebo condition we found increased activation in the left caudate and left cingulate gyrus during anticipation of reward. In the α-methylparatyrosine condition there was no significant brain activation during anticipation of reward or loss. In α-methylparatyrosine, anticipation of reward vs. loss increased activation in the right insula, left frontal, right parietal cortices and right cingulate gyrus. Comparing placebo versus α-methylparatyrosine showed increased activation in the left cingulate gyrus during anticipation of reward and the left medial frontal gyrus during anticipation of loss. α-methylparatyrosine reduced levels of dopamine in urine and homovanillic acid in plasma and increased prolactin. No significant effect of α-methylparatyrosine was found on norepinephrine markers. Our findings implicate distinct patterns of BOLD underlying reward processing following dopamine depletion, suggesting a role of dopaminergic neurotransmission for anticipation of monetary reward.
- 8 June 2010
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 25 (4) , 538-549
Dopaminergic modulation of the human reward system: a placebo-controlled dopamine depletion fMRI study
Reward related behaviour is linked to dopaminergic neurotransmission. Our aim was to gain insight into dopaminergic involvement in the human reward system. Combining functional magnetic resonance imaging with dopaminergic depletion by α-methylparatyrosine we measured dopamine-related brain activity in 10 healthy volunteers. In addition to blood-oxygen-level-dependent (BOLD) contrast we assessed the effect of dopaminergic depletion on prolactin response, peripheral markers for dopamine and norepinephrine. In the placebo condition we found increased activation in the left caudate and left cingulate gyrus during anticipation of reward. In the α-methylparatyrosine condition there was no significant brain activation during anticipation of reward or loss. In α-methylparatyrosine, anticipation of reward vs. loss increased activation in the right insula, left frontal, right parietal cortices and right cingulate gyrus. Comparing placebo versus α-methylparatyrosine showed increased activation in the left cingulate gyrus during anticipation of reward and the left medial frontal gyrus during anticipation of loss. α-methylparatyrosine reduced levels of dopamine in urine and homovanillic acid in plasma and increased prolactin. No significant effect of α-methylparatyrosine was found on norepinephrine markers. Our findings implicate distinct patterns of BOLD underlying reward processing following dopamine depletion, suggesting a role of dopaminergic neurotransmission for anticipation of monetary reward.